Picture of XBiotech logo

XBIT XBiotech Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m+5.64%
3m+74.53%
6m+42.55%
1yr+75.08%
Volume Change (%)
10d/3m+83.87%
Price vs... (%)
52w Highn/a
50d MA+30.28%
200d MA+52.26%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-17.01%
Return on Equity-10.69%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of XBiotech EPS forecast chart

Profile Summary

XBiotech Inc. is a biopharmaceutical company. The Company is engaged in advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases. The Company develops True Human monoclonal antibodies for treating a variety of diseases. True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The Company is focused on therapies that block a potent substance known as interleukin-1 alpha (IL-1a), which mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. IL-1a is a protein that is on or in cells of the body and is involved in the body’s response to injury or trauma, In almost all chronic and some acute injury scenarios (such as stroke or heart attack).

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 23rd, 2005
Public Since
April 15th, 2015
No. of Shareholders
11
No. of Employees
82
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
30,450,881
Blurred out image of a map
Address
5217 WINNEBAGO LANE, AUSTIN, 78744
Web
Phone
+1 5123862900
Auditors
Whitley Penn LLP

XBIT Share Price Performance

Upcoming Events for XBIT

Q1 2024 XBiotech Inc Earnings Release

XBiotech Inc Annual Shareholders Meeting

Q2 2024 XBiotech Inc Earnings Release

Similar to XBIT

Picture of 2Seventy Bio logo

2Seventy Bio

us flag iconNASDAQ Global Select Market

Picture of 4D Molecular Therapeutics logo

4D Molecular Therapeutics

us flag iconNASDAQ Global Select Market

Picture of AbCellera Biologics logo

AbCellera Biologics

us flag iconNASDAQ Global Select Market

Picture of AbSci logo

AbSci

us flag iconNASDAQ Global Select Market

Picture of Acadia Pharmaceuticals logo

Acadia Pharmaceuticals

us flag iconNASDAQ Global Select Market

FAQ